Renal lipotoxicity in diabetic and obesity‐associated kidney diseases: Molecular mechanisms and therapeutic targeting

Documenti analoghi

• Degree of joint risk factor control and incident chronic kidney disease among individuals with obesity
  di: Rui Tang, et al.
  Pubblicazione: (2024)
• Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
  di: Lijun Zhao, et al.
  Pubblicazione: (2024)
• Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study
  di: Huilin Tang, et al.
  Pubblicazione: (2025)
• Unveiling urinary diagnostic biomarkers for diabetic kidney disease using metabolomics and machine learning approaches
  di: Yuan Sun, et al.
  Pubblicazione: (2025)
• Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus
  di: Cheng Zu, et al.
  Pubblicazione: (2024)